These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295 [TBL] [Abstract][Full Text] [Related]
25. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients]. Jiang L; Yu JF Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611 [TBL] [Abstract][Full Text] [Related]
27. The venous ACT after heparin--how much discard? Chauhan S; Rao BH; Ghosh T; Sahu M; Kapoor M; Saxena N J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):721-2. PubMed ID: 9854678 [No Abstract] [Full Text] [Related]
28. Vascular effects of propofol during cardiopulmonary bypass. Hynynen M; Heinonen J Acta Anaesthesiol Scand; 1992 Aug; 36(6):600. PubMed ID: 1514351 [No Abstract] [Full Text] [Related]
29. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Fitzgerald D Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151 [No Abstract] [Full Text] [Related]
30. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293 [TBL] [Abstract][Full Text] [Related]
31. Lower dose of heparin for cardiopulmonary bypass is not necessarily associated with lower drainage loss. von Heymann C; Krimphove M; Spies C Eur J Cardiothorac Surg; 2005 Apr; 27(4):727; author reply 728. PubMed ID: 15784394 [No Abstract] [Full Text] [Related]
32. Mitral valve repair and cardiac transplantation in a patient with factor XII deficiency. Veronesi R; Maurelli M; Bianchi T; Toscani M; Via G; Villani MA; Pettinella S; Santambrogio LG; Fuardo M J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):419-20. PubMed ID: 16130082 [No Abstract] [Full Text] [Related]
33. Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass? Srivastava AR; Banerjee A; Misra BB; Minhas H; Virmani S J Card Surg; 2008; 23(3):239-45. PubMed ID: 18435639 [TBL] [Abstract][Full Text] [Related]
34. Validation of viscoelastic coagulation tests during cardiopulmonary bypass: reply. Ortmann E; Klein AA; Besser MW J Thromb Haemost; 2015 Dec; 13(12):2282. PubMed ID: 26407643 [No Abstract] [Full Text] [Related]
36. Lung perfusion during cardiac surgery with cardiopulmonary bypass: is it necessary? Gabriel EA; Fagionato Locali R; Katsumi Matsuoka P; Santiago Almeida L; Guerreiro Silva I; Capelozzi VL; Salerno TA; Buffolo E Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1089-95. PubMed ID: 18786945 [TBL] [Abstract][Full Text] [Related]
37. Anaesthesia for paediatric cardiac surgery at the Red Cross War Memorial Children's Hospital. Cooke RD S Afr Med J; 1984 Sep; 66(10):369-71. PubMed ID: 6484758 [TBL] [Abstract][Full Text] [Related]
38. Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time. McNulty SE; Maguire DP; Thomas RE J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):533-5. PubMed ID: 9801973 [TBL] [Abstract][Full Text] [Related]
39. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858 [TBL] [Abstract][Full Text] [Related]
40. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]